RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 101 - per page Next page
Order by
Profiled on pharmalicensing.com APR Applied Pharma Research S.A.
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare. More
Profiled on pharmalicensing.com Amarin Technologies S.A.
Amarin is engaged in the development of innovative pharmaceutical products using its proprietary topical and transdermal drug delivery technologies and know-how. More
Profiled on pharmalicensing.com CrystecPharma
CrystecPharma applies the latest supercritical fluid (SCF) technologies to improve the design and performance of medicines More
Embil Pharmaceutical Co. Ltd.
Pharmaceutical Formulation development, Manufacturing and Distribution More
Decision Resources Inc.
The worldwide leader in market research publications, advisory services and consulting More
Laboratorios Senosiain
Laboratorios Senosiain S.A. de C.V. is Mexican company dedicated to the development, production and comercialisation of quality pharmaceutical products. More
Palau Pharma
Palau Pharma is a product-driven biopharmaceutical company focused on the discovery and development of new medicines for the treatment of inflammatory and autoimmune diseases. More
Sciele Pharma Inc
Sciele Pharma Inc. acquires, develops, and markets prescription medicines within cardiovascular, obstetrical and gynaecological, paediatric and gastroenterological disorders More
Dar Al Dawa
Dar Al Dawa is a generic manufacturing company in the Middle East. More
Salvat
Independent Spanish owned pharmaceutical group identified with technological innovation, strongly committed to R&D. Development, manufacture and marketing of high-quality branded pharmaceuticals More
Displaying 1..10 of 101 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 84 pages - $500
Epidemiology: Rheumatoid Arthritis - Aging populations behind increases in patient populations
Mar 2011 - 23 pages - $5,700
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
Arthritis Therapy Area Pipeline Report
Nov 2010 - 382 pages - $1,495
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
Nov 2010 - 50 pages - $2,000
Rheumatoid Arthritis Therapy Area Pipeline Report
Nov 2010 - 1168 pages - $1,495
Rheumatoid Arthritis Market Assessment
Sep 2008 - $2,500
Systemic Juvenile Idiopathic Arthritis (SJIA) - Pipeline Review, Q4 2010
Dec 2010 - 27 pages - $500
Psoriatic Arthritis - Pipeline Review, H2 2011
Sep 2011 - 18 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us